• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

For DOCS, the Writing Is on the Wall

Doximity has not finished its decline, according to the charts.
By BRUCE KAMICH
Aug 05, 2022 | 02:49 PM EDT
Stocks quotes in this article: DOCS

Doximity ( DOCS)  is a n online professional networking platform that allows physicians, nurse practitioners and physician assistants to find each other and communicate without violating privacy laws. The company missed on revenue in earnings released Thursday night. A sell-side firm changed its fundamental rating to "Sell" from "Hold" and cut its price target. The firm cut forward guidance. 
 
Let's check out the charts and indicators. 
 
In this daily bar chart of DOCS, below, we can see that prices made a low in May and then rallied toward the underside of the declining 200-day moving average line. DOCS gapped below the 50-day moving average line today. The gap could get filled, but this probably will not improve the picture. The daily On-Balance-Volume (OBV) line is turning lower. The Moving Average Convergence Divergence (MACD) oscillator is pointed lower but still above the zero-line. 
 
 
 
In this weekly Japanese candlestick chart of DOCS, below, we can see two upper shadows as prices stopped short of the declining 40-week moving average line -- a sign that traders are rejecting the highs. The weekly OBV line is pointed down and the MACD oscillator, while rising, is still below the zero-line. 
 
 
 
In this daily Point and Figure chart of DOCS, below, we can see the price decline without a gap. A downside price target of $24 is indicated. 
 
 
 
In this weekly Point and Figure chart of DOCS, below, we can see a potential downside price target in the $21 area. 
 
 
 
Bottom line strategy: The charts of DOCS are weak. Avoid the long side.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Earnings | Investing | Technical Analysis | Science | Software & Services | Technology

More from Investing

McCormick Might Leave a Bad Taste in Investors' Mouths

Bruce Kamich
Oct 3, 2023 2:51 PM EDT

The charts don't look very appetizing for the spice company.

American Express: Leave Home Without It

Bruce Kamich
Oct 3, 2023 1:55 PM EDT

The charts show further declines ahead for the credit card company.

Costco: Are We Witnessing a Bull Trap?

Bruce Kamich
Oct 3, 2023 1:08 PM EDT

When one of the last holdouts of the S&P 500 turns down the selloff is in full gear.

Chasing Alpha With Alphabet

Ed Ponsi
Oct 3, 2023 12:35 PM EDT

I'm not the only one who likes the tech behemoth. Bill Ackman believes Alphabet will be a leader in AI for years to come.

Here's My Prescription for Eli Lilly Investors

Bruce Kamich
Oct 3, 2023 11:56 AM EDT

It looks like it's time to get off the meds, for now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:13 PM EDT BRUCE KAMICH

    8 Trading Rules from T. T. Hoyne

    You just read the header for this missive and prob...
  • 08:42 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How Elite Traders Make Big Profits
  • 02:58 PM EDT BRUCE KAMICH

    Classic Trading Rules From Bernard Baruch

    Bernard Baruch listed the rules (below) in his aut...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login